HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ling Yi Selected Research

Type 2 Diabetes Mellitus (MODY)

10/2019Study on Drug-Drug Interactions Between Chiglitazar, a Novel PPAR Pan-Agonist, and Metformin Hydrochloride in Healthy Subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ling Yi Research Topics

Disease

8Neoplasms (Cancer)
11/2022 - 01/2014
8Menkes Kinky Hair Syndrome (Menkes Disease)
09/2020 - 12/2011
5Lung Neoplasms (Lung Cancer)
01/2022 - 06/2015
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2022 - 04/2019
4Infections
01/2021 - 10/2004
3Pain (Aches)
01/2017 - 03/2009
2Circulating Neoplastic Cells
07/2021 - 04/2019
2Neurodegenerative Diseases (Neurodegenerative Disease)
09/2018 - 12/2011
2Dysmenorrhea (Menstrual Pain)
01/2017 - 01/2014
2Tuberculosis (Tuberculoses)
06/2015 - 12/2011
2Occipital horn syndrome
05/2015 - 05/2014
1Adenocarcinoma of Lung
11/2022
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2022
1Lewis Lung Carcinoma
01/2022
1Dehydration (Water Stress)
12/2021
1Shock
12/2021
1Dysbiosis
09/2021
1Fatty Liver
09/2021
1Congenital Abnormalities (Deformity)
01/2021
1Congenital Heart Defects (Congenital Heart Defect)
01/2021
1Atrial Heart Septal Defects (Atrial Septal Defect)
01/2021
1Stroke (Strokes)
10/2020
1Type 2 Diabetes Mellitus (MODY)
10/2019
1Breast Neoplasms (Breast Cancer)
07/2019
1Stillbirth
02/2016
1Lung Diseases (Lung Disease)
06/2015
1Pleural Effusion (Pleural Effusions)
06/2015
1Multiple Myeloma
08/2014
1Motor Neuron Disease (Primary Lateral Sclerosis)
05/2014
1Hypertension (High Blood Pressure)
01/2014
1Heart Neoplasms
01/2014
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
04/2012
1Muscular Diseases (Myopathy)
04/2012
1Dementia (Dementias)
04/2012
1Sepsis (Septicemia)
01/2012
1Inflammation (Inflammations)
03/2009

Drug/Important Bio-Agent (IBA)

4CopperIBA
09/2020 - 12/2011
4Proteins (Proteins, Gene)FDA Link
12/2019 - 05/2014
3CytokinesIBA
07/2021 - 01/2012
3Copper Transport ProteinsIBA
09/2018 - 04/2014
2LigandsIBA
11/2022 - 07/2021
2Messenger RNA (mRNA)IBA
12/2019 - 01/2015
2Monoclonal AntibodiesIBA
06/2015 - 01/2014
2P-type ATPasesIBA
05/2015 - 12/2011
1Immune Checkpoint ProteinsIBA
11/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Interleukin-10 (Interleukin 10)IBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Polyethylene Glycol 6000IBA
12/2021
1Abscisic AcidIBA
12/2021
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
12/2021
1Volatile Fatty AcidsIBA
09/2021
1PrebioticsIBA
09/2021
1ButyrophilinsIBA
03/2021
1Phenylalanine (L-Phenylalanine)FDA Link
01/2021
1Air Pollutants (Pollutants, Air)IBA
01/2021
1Environmental Pollutants (Pollutants, Environmental)IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
09/2020
1Complement System Proteins (Complement)IBA
09/2020
14-1BB Ligand (4 1BB Ligand)IBA
12/2019
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2019
1chiglitazarIBA
10/2019
1Tyrosine Kinase InhibitorsIBA
07/2019
1pyrotinibIBA
07/2019
1Programmed Cell Death 1 ReceptorIBA
06/2019
1AntigensIBA
06/2019
1ErbB Receptors (EGF Receptor)IBA
04/2019
1Pharmaceutical PreparationsIBA
01/2017
1Immune Checkpoint InhibitorsIBA
01/2017
1Dinoprostone (PGE2)FDA Link
01/2017
1Chimeric Antigen ReceptorsIBA
08/2014
1NucleotidesIBA
04/2014
1PhytochemicalsIBA
01/2014
1Plant ExtractsIBA
01/2014
1UbiquitinIBA
04/2012
1ChemokinesIBA
01/2012
1EnzymesIBA
12/2011
1Indicators and Reagents (Reagents)IBA
12/2011
1ImmunosorbentsIBA
12/2011
1Gold Colloid (Colloidal Gold)IBA
12/2011
1AntibodiesIBA
12/2011
1integrin alpha4beta7IBA
12/2009
1Iridoid GlucosidesIBA
03/2009
1harpagosideIBA
03/2009
1LuteolinIBA
10/2004
1beta-d-glucoseIBA
10/2004

Therapy/Procedure

2Therapeutics
11/2022 - 06/2019
2Moxibustion
01/2017 - 01/2014
1Immunotherapy
01/2022
1Immunomodulation
03/2021
1Secondary Prevention
10/2020
1Aftercare (After-Treatment)
01/2017
1Prenatal Care (Care, Prenatal)
02/2016